Searchable abstracts of presentations at key conferences in endocrinology

ea0027p42 | (1) | BSPED2011

Bone density in children with acute lymphoblastic leukaemia at a regional centre and comparison to children at risk of low bone density

Cockle Julia Veronica , Shaw Anita , Mushtaq Talat

Introduction: Improved survival in childhood acute lymphoblastic leukaemia (ALL) has highlighted the importance of recognising and preventing skeletal morbidity. This study aims to assess bone health of ALL patients and compare this to other paediatric patients with chronic illness.Methods: Dual energy absorptiometry (DXA) scan results for total body bone mineral density (TBBMD), lumbar spine bone mineral apparent density (LSBMAD) and total body less hea...

ea0023p21 | (1) | BSPED2009

Adrenal hypoplasia congenita presenting as sudden death in the newborn: how should we manage subsequent siblings?

Alvi Sabah , Basu Shimona , Mushtaq Talat

Introduction: Adrenal hypoplasia congenita (AHC) is often difficult to differentiate from congenital adrenal hyperplasia in the early stages of life. Both can present with severe salt-losing crises, and in some cases, even sudden, unexpected death. In particular there tend to be no abnormalities of the genitilia in AHC thus delaying a possible diagnosis. In the autosomal recessive form of AHC, the absence of a recognised single gene mutation can cause significant difficulties ...

ea0051p047 | Pituitary and growth | BSPED2017

Frequency of cranial MRI abnormalities in isolated growth hormone deficiency over a 20-year period

Biliaieva Kateryna , Amin Nadia , Chowdhury Sudip , Mushtaq Talat

Background: Patients with isolated growth hormone deficiency (GHD) will routinely have an MRI scan of the pituitary and brain to assess pituitary size and presence of any intracranial lesions. The result may change the threshold for monitoring for further hormone deficiencies. However the test may also detect unexpected or unrelated abnormalities.Aim: To review the incidence of normal and abnormal MRI scans in children with a diagnosis of isolated GHD.</...

ea0039oc5.7 | Oral Communications 5 | BSPED2015

Prevalence, management, and long-term outcomes of osteonecrosis in young people with acute lymphoblastic leukaemia

Amin Nadia , Kinsey Sally , Feltbower Richard , Mushtaq Talat , James Beki

Introduction: Osteonecrosis is an increasingly common complication in young people treated for acute lymphoblastic leukaemia (ALL). This is likely to be due to the now universal use of high dose steroids.Aim: The aim of this study was to obtain information on prevalence, current UK management and long-term outcomes of patients.Methods: We retrospectively collated data on patients with osteonecrosis for the most recently completed t...

ea0036oc5.2 | Oral Communications 5 | BSPED2014

The impact of receiving a diagnosis of congenital hypothyroidism on families

Alvi Sabah , Priestley Julia , Whitehead Amanda , Walker Jenny , Mushtaq Talat

Background: Congenital hypothyroidism (CHT) may be viewed as a relatively easy condition to diagnose and treat. However, for the parents who are contacted with the neonatal screening results the news can be devastating. The quality of information provided at diagnosis is variable, and there are few support groups they can turn to. Many seek information online before meeting a paediatrician.Methods: The British Thyroid Foundation in conjunction with our r...

ea0058p022 | Growth | BSPED2018

You are what you eat: gonadotrophin independent precocious puberty

Jackson Charlotte , Peacock Amanda , Mushtaq Talat , Chowdhury Nazma , Wei Christina

Introduction: Phytoestrogens are derived from plants that are structurally and functionally similar to oestrogens. Their health benefits are widely extolled, although excessive consumption in children may cause adverse effects.Case 1: A 5.7-year old female presented with a one-month history of breast development and a 3-day history of vaginal bleeding. Prior to presentation, she was taking a health drink containing fennel and sesame seeds, in addition to...

ea0027oc2.4 | Oral Communications 2 (Quick Fire) | BSPED2011

Short term effects of recombinant IGF1 therapy in children with Laron's syndrome

Amin Nadia , Alvi Sabah , Walker Jenny , Whitehead Amanda , Mushtaq Talat

Introduction: Children with Laron’s syndrome have a classical phenotype which includes extreme short stature and mid facial hypoplasia. It is biochemically characterised by high levels of GH and very low IGF1 levels. These children fulfil the criteria for recombinant IGF1 (rhIGF1, Mecasermin) therapy, however this has to be balanced with possible side effects. This study looked at the short term efficacy and safety profile of six children (five males) with Laron’s sy...

ea0095p13 | Bone | BSPED2023

Cessation of burosumab treatment in adolescent patients with XLH: A multi-centre case series

Uday Suma , Jarvis Charlotte , Ramakrishnan Renuka , Mushtaq Talat , Williams Angela

Background: X-linked hypophosphataemia (XLH) is a genetic condition that causes significant skeletal deformities and is associated with lifelong disability and pain. In October 2018, the NHS in England recommended burosumab, an anti-FGF23 antibody, for treating XLH with radiographic evidence of bone disease in children aged 1 year and over, and in young people with growing bones. The clinical and cost effectiveness of burosumab for treating adults with XLH is ...

ea0051p053 | Pituitary and growth | BSPED2017

Growth hormone treatment in a regional centre: licensed and unlicensed indications

Whitehead Mandy , Tseretopoulou Xanthippi , Cottrell-Jane Emily , Alvi Sabah , Mushtaq Talat

Introduction: In the UK, GH therapy is licensed for use in GH deficiency, Turner Syndrome, Small for Gestational Age (SGA), Prader Willi Syndrome (PWS), SHOX deletion and Chronic Renal Failure (CRF). Worldwide there are a number of additional indications. The aim was to review the use of GH prescriptions in relation to indications and to evaluate if there were similarities or differences between the licensed and unlicensed groups.Methods: All children st...

ea0039ep70 | Gonadal, DSD and reproduction | BSPED2015

Chromosomal variations in children and adolescents with gender dysphoria: is routine karyotyping indicated?

Goedhardt Claire , Brain Caroline , Viner Russell , Butler Gary , Alvi Sabah , Mushtaq Talat , Walker Jenny , The Team

Background: Chromosome analysis is always indicated in disorders of sex development (DSD), but the need for karyotyping in gender dysphoria (GD) is less clear.Aims and objectives: We therefore aimed to review the place of routine chromosome analysis in the management of GD in children and adolescents.Patients and methods: Five hundred and twenty children and adolescents with GD have been referred at the time of reporting to the two...